Viridian Therapeutics, Inc.\DE (VRDN) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for Viridian Therapeutics, Inc.\DE (VRDN) over the last 5 years, with Q3 2025 value amounting to $5.5 million.
- Viridian Therapeutics, Inc.\DE's Interest & Investment Income fell 2653.36% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year decrease of 41.69%. This contributed to the annual value of $32.1 million for FY2024, which is 7309.7% up from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Interest & Investment Income stood at $5.5 million for Q3 2025, which was down 2653.36% from $6.5 million recorded in Q2 2025.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Interest & Investment Income peaked at $9.1 million during Q4 2024, and registered a low of $34000.0 during Q2 2021.
- Its 5-year average for Interest & Investment Income is $4.2 million, with a median of $4.4 million in 2023.
- Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 239927.54% in 2022, then tumbled by 2653.36% in 2025.
- Viridian Therapeutics, Inc.\DE's Interest & Investment Income (Quarter) stood at $138000.0 in 2021, then soared by 2399.28% to $3.4 million in 2022, then surged by 60.45% to $5.5 million in 2023, then surged by 63.62% to $9.1 million in 2024, then crashed by 39.03% to $5.5 million in 2025.
- Its Interest & Investment Income stands at $5.5 million for Q3 2025, versus $6.5 million for Q2 2025 and $7.5 million for Q1 2025.